Vascular Access Devices | Market Insights | US | 2021
The US market for vascular access devices is mature and will contract slightly over the forecast period. Rising unit sales, driven by an increasing patient pool in the US, will be offset by strong pricing pressures, which will result in declining ASPs in most product segments. Furthermore, recent physician-led guidelines will continue to drive a shift in vascular access device selection toward the use of less expensive midline catheters at the expense of PICCs, which will also contribute to declines in overall market revenue. Importantly, the impact of the COVID-19 pandemic on procedures, unit sales, and revenues has been incorporated into the market projections.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Vascular Access Devices in the US across a 10-year period.
